Transduction efficiency
| Animal no. . | IS regimen . | Vector copy number/ diploid genome at wk 8 . |
|---|---|---|
| 1001 | None | 1.1176 |
| 1002 | None | 0.8656 |
| 1003 | None | 0.9892 |
| 2001 | MMF, sirolimus, daclizumab | 0.3597 |
| 2002 | MMF, sirolimus, daclizumab | 1.5664 |
| 2003 | MMF, sirolimus, daclizumab | 0.0930 |
| 3001 | MMF, sirolimus | 1.7639 |
| 3002 | MMF, sirolimus | 0.2242 |
| 3003 | MMF, sirolimus | 0.5762 |
| Animal no. . | IS regimen . | Vector copy number/ diploid genome at wk 8 . |
|---|---|---|
| 1001 | None | 1.1176 |
| 1002 | None | 0.8656 |
| 1003 | None | 0.9892 |
| 2001 | MMF, sirolimus, daclizumab | 0.3597 |
| 2002 | MMF, sirolimus, daclizumab | 1.5664 |
| 2003 | MMF, sirolimus, daclizumab | 0.0930 |
| 3001 | MMF, sirolimus | 1.7639 |
| 3002 | MMF, sirolimus | 0.2242 |
| 3003 | MMF, sirolimus | 0.5762 |
No statistically significant differences detected.